Bifogade filer
PDF
Kurs
-14,99%
Likviditet
0,85 MSEK
Kalender
| Est. tid* | ||
| 2025-11-15 | 08:50 | Kvartalsrapport 2025-Q3 |
| 2025-10-03 | - | Extra Bolagsstämma 2025 |
| 2025-08-22 | - | Kvartalsrapport 2025-Q2 |
| 2025-06-17 | - | Årsstämma |
| 2025-06-12 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2025-05-28 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-19 | - | Bokslutskommuniké 2024 |
| 2024-11-15 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-12 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2024-06-11 | - | Årsstämma |
| 2024-05-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-23 | - | Bokslutskommuniké 2023 |
| 2024-01-11 | - | Extra Bolagsstämma 2023 |
| 2023-11-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-07-06 | - | Split SIN 100:1 |
| 2023-06-12 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2023-06-09 | - | Årsstämma |
| 2023-05-17 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-12-27 | - | Extra Bolagsstämma 2022 |
| 2022-10-24 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-27 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2022-04-26 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-11-16 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-27 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2021-04-26 | - | Årsstämma |
| 2021-02-19 | - | Bokslutskommuniké 2020 |
| 2021-02-02 | - | Extra Bolagsstämma 2021 |
| 2020-11-20 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | Extra Bolagsstämma 2020 |
| 2020-03-31 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2020-03-30 | - | Årsstämma |
| 2020-02-18 | - | Bokslutskommuniké 2019 |
| 2019-11-20 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-22 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-29 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2019-03-28 | - | Årsstämma |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-03 | - | X-dag ordinarie utdelning SIN 0.00 SEK |
| 2018-05-02 | - | Årsstämma |
| 2018-04-27 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-20 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Stockholm - 2025-10-03
Evolear AB (name change pending to Solution International Nordics AB) announces that the Board of Directors has appointed Mark McLoughlin as Chief Executive Officer. Mark assumes the role today.
Mark founded Solution more than 15 years ago and holds a degree in Business from Oxford Brookes University. Within Solution, Mark has previously served first as CFO then CEO. Prior to Solution, he held the position of Finance Director at Euromark PLC, and worked in the investment banking divisions of Credit Suisse, as well as at JP Morgan and Coca-Cola.
For further information, please contact:
Board of Directors
Evolear AB (publ), name change pending Solution International Nordics AB (publ)
Email ir@solutioninternational.com
www.solutioneu.com / ir.evolear.com
About
Solution International is an award-winning, full-service supplier of quality product for baby, kids and parents known for high quality and reliable delivery of product innovation. Strategically headquartered in the UK for logistical efficiencies, the company maintains in-house teams across product development, design, marketing, and logistics to ensure end-to-end control of the supply chain.